104
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Obesity: outcome of standardized life-style change in a rehabilitation clinic. An observational study

, , , , &
Pages 813-820 | Published online: 27 May 2019

References

  • Whiting DR , Guariguata L , Weil C , Shaw J . IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract . 2011;94(3):311–321. doi:10.1016/j.diabres.2011.10.029 22079683
  • World Health Organization. Obesity: Preventing and Managing the Global Epidemic . Geneva: World Health Organization; 2000.
  • Gregg EW , Shaw JE . Global health effects of overweight and obesity. N Engl J Med . 2017;377(1):80–81. doi:10.1056/NEJMe1706095 28604226
  • Zimmet P , Alberti KG , Shaw J . Global and societal implications of the diabetes epidemic. Nature . 2001;414(6865):782–787. doi:10.1038/414782a 11742409
  • Roden M , Price TB , Perseghin G , et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest . 1996;97(12):2859–2865. doi:10.1172/JCI118742 8675698
  • Shai I , Schwarzfuchs D , Henkin Y , et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med . 2008;359(3):229–241. doi:10.1056/NEJMoa0708681 18635428
  • Heymsfield SB , Wadden TA . Mechanisms, pathophysiology, and management of obesity. N Engl J Med . 2017;376(3):254–266. doi:10.1056/NEJMra1514009 28099824
  • Adams TD , Davidson LE , Litwin SE , et al. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med . 2017;377(12):1143–1155. doi:10.1056/NEJMoa1700459 28930514
  • Fabbrini E , Yoshino J , Yoshino M , et al. Metabolically normal obese people are protected from adverse effects following weight gain. J Clin Invest . 2015;125(2):787–795. doi:10.1172/JCI78425 25555214
  • Jais A , Einwallner E , Sharif O , et al. Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man. Cell . 2014;158(1):25–40. doi:10.1016/j.cell.2014.04.043 24995976
  • Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA . 2001;285(19):2486–2497.11368702
  • Smith SA , Poland GA . Influenza and pneumococcal immunization in diabetes. Diabetes Care . 2004;27 Suppl 1:S111–S113.14693944
  • World Health Organization. WHO STEPS surveillance manual; 2017 Available from: https://www.who.int/ncds/surveillance/steps/STEPS_Manual.pdf. Accessed 8 22, 2018.
  • Lee DY , Lee MY , Sung KC . Prediction of mortality with A Body Shape Index in Young Asians: comparison with body mass index and waist circumference. Obesity . 2018;26(6):1096–1103. doi:10.1002/oby.22193 29719128
  • Krakauer NY , Krakauer JC . A new body shape index predicts mortality hazard independently of body mass index. PLoS One . 2012;7(7):e39504. doi:10.1371/journal.pone.0039504 22815707
  • Framingham Heart Study. Hard coronary heart disease (10-year risk); 2018 Available form: https://www.framinghamheartstudy.org/fhs-risk-functions/hard-coronary-heart-disease-10-year-risk/. Accessed 8 22, 2018.
  • Hirst JA , Stevens RJ , Farmer AJ . Changes in HbA1c level over a 12-week follow-up in patients with type 2 diabetes following a medication change. PLoS One . 2014;9(3):e92458. doi:10.1371/journal.pone.0092458 24667212
  • Marathe PH , Gao HX , Close KL . American diabetes association standards of medical care in diabetes 2017. J Diabetes . 2017;9(4):320–324. doi:10.1111/1753-0407.12524 28070960
  • Larsson A , Hansson LO , Akerfeldt T . Weight reduction is associated with decreased CRP levels. Clin Lab . 2013;59(9–10):1135–1138.24273938
  • Petersen KF , Dufour S , Befroy D , Lehrke M , Hendler RE , Shulman GI . Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes . 2005;54(3):603–608.15734833
  • Sato F , Tamura Y , Watada H , et al. Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects. J Clin Endocrinol Metab . 2007;92(8):3326–3329. doi:10.1210/jc.2006-2384 17519317
  • Taylor R . Type 2 diabetes: etiology and reversibility. Diabetes Care . 2013;36(4):1047–1055. doi:10.2337/dc12-1805 23520370
  • Moller K , Ostermann AI , Rund K , et al. Influence of weight reduction on blood levels of C-reactive protein, tumor necrosis factor-alpha, interleukin-6, and oxylipins in obese subjects. Prostaglandins Leukot Essent Fatty Acids . 2016;106:39–49. doi:10.1016/j.plefa.2015.12.001 26751601
  • Pi-Sunyer FX . Short-term medical benefits and adverse effects of weight loss. Ann Intern Med . 1993;119(7 Pt 2):722–726.8363205
  • Mancuso P . Obesity and respiratory infections: does excess adiposity weigh down host defense? Pulm Pharmacol Ther . 2013;26(4):412–419. doi:10.1016/j.pupt.2012.04.006 22634305
  • Rutqvist LE . Population-based survey of cessation aids used by Swedish smokers. Harm Reduct J . 2012;9:38. doi:10.1186/1477-7517-9-38 23206988
  • Rawshani A , Rawshani A , Franzen S , et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med . 2017;376(15):1407–1418. doi:10.1056/NEJMoa1608664 28402770
  • Caleyachetty R , Thomas GN , Toulis KA , et al. Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women. J Am Coll Cardiol . 2017;70(12):1429–1437. doi:10.1016/j.jacc.2017.07.763 28911506
  • Chiasson JL , Josse RG , Gomis R , Hanefeld M , Karasik A , Laakso M . Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet . 2002;359(9323):2072–2077. doi:10.1016/S0140-6736(02)08905-5 12086760
  • Knowler WC , Barrett-Connor E , Fowler SE , et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med . 2002;346(6):393–403. doi:10.1056/NEJMoa012512 11832527
  • Bleich SN . A road map for sustaining healthy eating behavior. N Engl J Med . 2018;379(6):507–509. doi:10.1056/NEJMp1805494 30089073
  • Jackson MY , Proulx JM , Pelican S . Obesity prevention. Am J Clin Nutr . 1991;53(6 Suppl):1625s–1630s.2031497
  • Block JP . The Calorie-Labeling Saga - federal preemption and delayed implementation of public health law. N Engl J Med . 2018;379(2):103–105. doi:10.1056/NEJMp1802953 29791255